|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2010-6-2
|
|
pubmed:abstractText |
Mutations in the fibroblast growth factor receptor 3 (FGFR3) have been found in 70% of the low-grade non-muscle-invasive bladder cancer (NMI-BC) tumors. We aim to determine the potential of FGFR3 mutation analysis on voided urine to detect recurrences during surveillance of patients with low-grade NMI-BC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2010 AACR.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3011-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20404005-Adult,
pubmed-meshheading:20404005-Aged,
pubmed-meshheading:20404005-Aged, 80 and over,
pubmed-meshheading:20404005-DNA Mutational Analysis,
pubmed-meshheading:20404005-Female,
pubmed-meshheading:20404005-Humans,
pubmed-meshheading:20404005-Male,
pubmed-meshheading:20404005-Middle Aged,
pubmed-meshheading:20404005-Mutation,
pubmed-meshheading:20404005-Predictive Value of Tests,
pubmed-meshheading:20404005-Receptor, Fibroblast Growth Factor, Type 3,
pubmed-meshheading:20404005-Recurrence,
pubmed-meshheading:20404005-Sensitivity and Specificity,
pubmed-meshheading:20404005-Urinary Bladder Neoplasms
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer.
|
|
pubmed:affiliation |
Department of Pathology, Erasmus Medical Center, Rotterdam, the Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
